General Info

Since 2003, RegenLab has been committed to the development of a unique expertise in the design and manufacturing of high-quality medical devices, intended for the preparation of cellular therapies and autologous platelet-rich plasma (PRP) from the patients own blood. Bringing these technologies to the United States in 2013, RegenLab USA offers Regen A-PRP and Autologous Thrombin Serum with a focus on product quality, patient safety, and preparation efficiency. Now in 2022, RegenLab is proud to be manufactured in the USA. As we look to the future, we are committed to guiding new standards for emerging categories within the field of regenerative medicine.